(Q38782387)

6 September 2017

title

Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

6 September 2017

main subject

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Yu Wu

1

1 reference

6 September 2017

Kun L Ma

2

1 reference

6 September 2017

Yang Zhang

3

1 reference

6 September 2017

Yi Wen

4

1 reference

6 September 2017

Gui H Wang

5

1 reference

6 September 2017

Ze B Hu

6

1 reference

6 September 2017

Liang Liu

7

1 reference

6 September 2017

Jian Lu

8

1 reference

6 September 2017

Pei P Chen

9

1 reference

6 September 2017

Xiong Z Ruan

10

1 reference

6 September 2017

Bi C Liu

11

1 reference

6 September 2017

language of work or name

1 reference

30 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

36

1 reference

6 September 2017

issue

10

1 reference

6 September 2017

page(s)

1525-1534

1 reference

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

6 September 2017

cites work

1 reference

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis

21 January 2018

1 reference

Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis

21 January 2018

1 reference

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice

21 January 2018

1 reference

Obesity and free fatty acids

21 January 2018

1 reference

Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin

21 January 2018

1 reference

Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats

21 January 2018

1 reference

Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance

21 January 2018

1 reference

Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction

21 January 2018

1 reference

Mitochondria and redox signaling in steatohepatitis

21 January 2018

1 reference

Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue

21 January 2018

1 reference

Central adiposity, systemic inflammation, and the metabolic syndrome

21 January 2018

1 reference

Renin-angiotensin system in the pathogenesis of liver fibrosis

21 January 2018

1 reference

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

Activation of renin-angiotensin system is involved in dyslipidemia-mediated renal injuries in apolipoprotein E knockout mice and HK-2 cells

21 January 2018

1 reference

Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis

21 January 2018

1 reference

Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB

21 January 2018

1 reference

Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

21 January 2018

1 reference

Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats

21 January 2018

1 reference

Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats

21 January 2018

1 reference

Liver fibrosis: a balance of ACEs?

21 January 2018

1 reference

Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease

21 January 2018

1 reference

LOX-1: a critical player in the genesis and progression of myocardial ischemia

21 January 2018

1 reference

The renin-angiotensin system and diabetic nephropathy

21 January 2018

1 reference

Effects of angiotensin II receptor blockers on diabetic nephropathy

21 January 2018

1 reference

Dual effects of RAS blockade on blood pressure and podocyte function

21 January 2018

1 reference

Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.13131

1 reference

release_aoyb3miyinbqfamg5xnel3zmjy

6 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aoyb3miyinbqfamg5xnel3zmjy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference